We are live on ! Find out more
MGNX icon

MacroGenics

147 hedge funds and large institutions have $1.23B invested in MacroGenics in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 64 increasing their positions, 35 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

83% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 35

53% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 15

6% more funds holding

Funds holding: 139147 (+8)

3.98% less ownership

Funds ownership: 99.68%95.7% (-4%)

7% less capital invested

Capital invested by funds: $1.33B → $1.23B (-$97.7M)

52% less call options, than puts

Call options by funds: $1.76M | Put options by funds: $3.67M

Holders
147
Holders Change
+8
Holders Change %
+5.76%
% of All Funds
2.6%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
23
Increased
64
Reduced
35
Closed
15
Calls
$1.76M
Puts
$3.67M
Net Calls
-$1.9M
Net Calls Change
-$1.89M
Name Holding Trade Value Shares
Change
Change in
Stake
Truist Financial
76
Truist Financial
North Carolina
$752K +$54K +2,345 +8%
Manulife (Manufacturers Life Insurance)
77
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$747K +$60.8K +2,639 +9%
Jennison Associates
78
Jennison Associates
New York
$747K +$110K +4,772 +17%
Los Angeles Capital Management
79
Los Angeles Capital Management
California
$719K +$724K +31,466 New
MML Investors Services
80
MML Investors Services
Massachusetts
$716K +$721K +31,300 New
VOYA Investment Management
81
VOYA Investment Management
Georgia
$674K +$124K +5,407 +22%
T. Rowe Price Associates
82
T. Rowe Price Associates
Maryland
$672K +$279K +12,106 +70%
ECM
83
EMC Capital Management
Texas
$572K +$576K +25,031 New
State Board of Administration of Florida Retirement System
84
State Board of Administration of Florida Retirement System
Florida
$566K -$3.45K -150 -0.6%
Ameriprise
85
Ameriprise
Minnesota
$544K +$547K +23,778 New
Rafferty Asset Management
86
Rafferty Asset Management
New York
$514K -$689K -29,933 -57%
MIM
87
MetLife Investment Management
New Jersey
$514K
Stifel Financial
88
Stifel Financial
Missouri
$481K +$37.5K +1,628 +8%
Axa
89
Axa
France
$480K +$483K +21,000 New
ProShare Advisors
90
ProShare Advisors
Maryland
$476K +$130K +5,629 +37%
AC
91
Athanor Capital
New York
$475K +$196K +8,495 +69%
AG
92
Aperio Group
California
$463K +$98.3K +4,268 +27%
Barclays
93
Barclays
United Kingdom
$458K -$153K -6,631 -25%
SMH
94
Sanders Morris Harris
Texas
$426K
EAM
95
Erste Asset Management
Austria
$411K +$414K +18,000 New
SG Americas Securities
96
SG Americas Securities
New York
$406K +$37.6K +1,631 +10%
EWM
97
Evercore Wealth Management
New York
$401K
CL
98
CSS LLC
Illinois
$392K +$163K +7,070 +70%
WG
99
Winton Group
United Kingdom
$372K +$375K +16,273 New
Citigroup
100
Citigroup
New York
$364K +$154K +6,679 +72%

MGNX Hedge Fund Activity: Q4 2020 in Review

147 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q4 2020, worth a combined $1.23B — down 7.4% from $1.33B a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new MGNX positions and 15 closed out — a net gain of 8 holders — while 64 added to existing stakes and 35 trimmed.

The largest buyer was Wasatch Advisors, adding an estimated $28.5M. The largest seller was Point72 Asset Management, cutting an estimated $49.2M.

  • 147 institutional investors held MacroGenics (MGNX) as of Q4 2020, up from 139 in Q3 2020.
  • Funds reported $1.23B of MacroGenics stock for Q4 2020, down 7.4% quarter-over-quarter.
  • 23 funds opened new MacroGenics positions in Q4 2020 and 15 closed out, a net change of +8 holders.
  • The largest MacroGenics buyer in Q4 2020 was Wasatch Advisors, an estimated $28.5M added.
  • The largest MacroGenics seller in Q4 2020 was Point72 Asset Management, an estimated $49.2M sold.

Based on aggregated 13F filings for Q4 2020.